|
DE4302485A1
(de)
*
|
1993-01-29 |
1994-08-04 |
Merck Patent Gmbh |
Piperazinderivate
|
|
FR2768729A1
(fr)
|
1997-09-19 |
1999-03-26 |
Rhodia Chimie Sa |
Procede d'acylation d'un compose aromatique et complexes catalytiques
|
|
FR2768728B1
(fr)
|
1997-09-19 |
1999-12-03 |
Rhodia Chimie Sa |
Procede d'acylation d'un compose aromatique
|
|
US7629360B2
(en)
|
1999-05-07 |
2009-12-08 |
Celgene Corporation |
Methods for the treatment of cachexia and graft v. host disease
|
|
KR20070106969A
(ko)
*
|
2004-09-09 |
2007-11-06 |
추가이 세이야쿠 가부시키가이샤 |
신규 이미다졸리딘 유도체 및 그 용도
|
|
WO2007073432A2
(en)
|
2005-10-11 |
2007-06-28 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
|
WO2007136640A2
(en)
|
2006-05-16 |
2007-11-29 |
Celgene Corporation |
Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
|
|
WO2011008260A2
(en)
|
2009-07-13 |
2011-01-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
RU2434851C1
(ru)
|
2010-07-22 |
2011-11-27 |
Александр Васильевич Иващенко |
Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения
|
|
US8765978B2
(en)
|
2010-12-16 |
2014-07-01 |
Transitions Optical, Inc. |
Method of making indeno-fused naphthol materials
|
|
WO2012119559A1
(en)
|
2011-03-10 |
2012-09-13 |
Suzhou Kintor Pharmaceuticals,Inc. |
Androgen receptor antagonists and uses thereof
|
|
US20140112922A1
(en)
|
2011-03-28 |
2014-04-24 |
Cornell University |
Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes
|
|
KR102438072B1
(ko)
|
2012-01-12 |
2022-08-31 |
예일 유니버시티 |
E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법
|
|
SI2894151T1
(sl)
*
|
2012-09-04 |
2021-01-29 |
Shanghai Hengrui Pharmaceutical Co. Ltd. |
Imidazolinski derivati, postopki za njihovo pripravo in njihove uporabe v medicini
|
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
KR102226587B1
(ko)
|
2013-01-31 |
2021-03-11 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 퀴놀린 및 퀴나졸린 아미드
|
|
US20160058872A1
(en)
|
2014-04-14 |
2016-03-03 |
Arvinas, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
EP4649963A3
(en)
|
2014-04-14 |
2026-05-13 |
Arvinas Operations, Inc. |
Imide-based modulators of proteolysis and associated methods of use
|
|
RU2557235C1
(ru)
*
|
2014-07-08 |
2015-07-20 |
Александр Васильевич Иващенко |
Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты
|
|
JP6815318B2
(ja)
|
2014-12-23 |
2021-01-20 |
ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド |
二官能性分子によって標的化タンパク質分解を誘導する方法
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
JP6817962B2
(ja)
|
2015-01-20 |
2021-01-20 |
アルビナス・オペレーションズ・インコーポレイテッドArvinas Operations, Inc. |
ターゲティングされたアンドロゲン受容体分解のための化合物および方法
|
|
AU2016232705C1
(en)
|
2015-03-18 |
2021-06-17 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
GB201506871D0
(en)
|
2015-04-22 |
2015-06-03 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
EP3319944A4
(en)
|
2015-07-10 |
2019-04-24 |
Arvinas, Inc. |
MDM2-BASED MODULATORS OF PROTEOLYSIS AND RELATED USE METHODS
|
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
|
WO2018009694A1
(en)
*
|
2016-07-08 |
2018-01-11 |
Janssen Pharmaceutica Nv |
Thiohydantoin androgen receptor antagonists for the treatment of cancer
|
|
TWI739888B
(zh)
|
2016-10-07 |
2021-09-21 |
美商陶氏農業科學公司 |
農藥組合物及方法
|
|
SI3526202T1
(sl)
|
2016-10-11 |
2025-04-30 |
Arvinas Operations, Inc. |
Spojine in postopki za ciljno razgradnjo androgenskih receptorjev
|
|
WO2018089736A1
(en)
|
2016-11-10 |
2018-05-17 |
Dana-Farber Cancer Institute, Inc. |
Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use
|
|
AU2017363257B2
(en)
|
2016-11-22 |
2021-08-19 |
Dana-Farber Cancer Institute, Inc. |
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
|
|
RU2747260C2
(ru)
|
2016-12-19 |
2021-04-29 |
Аббиско Тхерапеутицс Цо., Лтд. |
Ингибитор рфрф4, способ его получения и его фармацевтическое применение
|
|
IL319363A
(en)
|
2017-01-31 |
2025-05-01 |
Arvinas Operations Inc |
Cervalon ligands and bifunctional compounds containing them
|
|
EP4717317A3
(en)
|
2017-06-20 |
2026-06-03 |
C4 Therapeutics, Inc. |
N/o-linked degrons and degronimers for protein degradation
|
|
CN109422725A
(zh)
|
2017-09-04 |
2019-03-05 |
北京美倍他药物研究有限公司 |
前列腺癌治疗药物
|
|
HUE064356T2
(hu)
|
2017-11-28 |
2024-03-28 |
Aarti Pharmalabs Ltd |
Eljárás enzalutamid elõállítására új intermedier felhasználásával
|
|
CN111163638B
(zh)
|
2017-12-05 |
2023-07-25 |
美国陶氏益农公司 |
杀有害生物组合物和方法
|
|
AU2019276514B2
(en)
|
2018-05-30 |
2023-12-14 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Inhibitor containing tricyclic derivative, preparation method therefor, and application thereof
|
|
CN109651256A
(zh)
|
2018-11-20 |
2019-04-19 |
上海健康医学院 |
一种式(viii)的恩杂鲁胺的制备方法
|
|
BR112021011968A2
(pt)
|
2018-12-19 |
2021-09-08 |
Celgene Corporation |
Compostos de 3-((3-aminofenil)amino)piperidina-2,6-diona substituídos, composições dos mesmos e métodos de tratamento com os mesmos
|